Indian biogenerics could form a major piece of the global biotherapeutics market in the future.
Feb 1, 2008
By:
Eric S. Langer
Indian biogenerics could form a major piece of the global biotherapeutics market in the future.
|
India has made great strides in the development of its biopharmaceutical industry
Jan 1, 2008
By:
Eric S. Langer
India's biopharmaceutical industry, which was relatively modest only a decade ago, is expected to generate almost $2 billion in sales in 2008, making it one of the largest biopharmaceutical segments in Asia.1 According to BioPlan Associates, Inc., and the Society for Industrial Microbiology's newly published joint study, Advances in Biopharmaceutical Technology in India, the Indian biopharmaceutical industry is growing 25 to 30% per year.1
|
Despite serious obstacles, development marches ahead
Dec 1, 2007
By:
Eric S. Langer
China's pharma industry represents 5% of the world total. By 2010, China is expected to become the world's fifth largest pharmaceutical market.
|
Changes in the quality of Chinese universities has allowed the biotechnology sector to grow
Nov 1, 2007
By:
Eric S. Langer, Eliza Yibing Zhou
Biotechnology is definitely a hot topic in China—the country's administrators recently identified it as a "cornerstone of China's national economy by 2020." But most realize that getting there will require a better trained, specialized workforce than currently exists. The Chinese government has been pumping money into life sciences education as part of its plan to achieve a global biotechnological presence over the next 15 years.
|
Converting China's pharmaceutical manufacturing capacity to biopharmaceutical exports
Aug 1, 2007
By:
Eric S. Langer
In 2006, China exported a total of $890 million in biologics to other countries—a 30.61% increase, compared with the previous year.
|
The need for speed in scientific discovery may hinder authentic knowledge exchange
Jul 1, 2007
By:
Eric S. Langer
Sir Isaac Newton said, back in 1676, "If I have seen further, it is by standing on the shoulders of Giants." Newton's modest self-assessment of his scientific competence holds relevance in today's debate on the value of scientific meetings, and our quest for faster scientific discovery.
|
China's large domestic market potential and its competence in producing biogenerics are driving its future direction
Jun 1, 2007
By:
Eric S. Langer
In China, the presence of a substantial biogenerics industry reflects a growing need to provide healthcare to domestic populations, at a reasonable cost.
|
|
Users and vendors convene at an IVT meeting on disposables to discuss the potential of single-use technology in bioproduction over the next 10 years.
Jun 1, 2007
By:
Eric S. Langer, Brandon J. Price
Today, most disposables are used for process development and clinical-scale manufacturing. Substantial growth in disposables usage may not occur until disposables are incorporated into the production of licensed products at commercial scale.
|
The recent rise in patent application filings reflects new confidence in the future of patent protection
May 1, 2007
By:
Eric S. Langer
China's central government is aware of the need to improve intellectual property protection and enforcement.
|
|
